Blood coagulation and fibrinolysis in hyperthermic rats. 1987

P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
D. Danielopolu Institute of Normal and Pathological Physiology, Bucharest, Romania.

Exposure of rats to an environment of +40 degrees C that increases central (rectal) temperature to about 40 degrees C, importantly decrease the number of thrombocytes, the blood coagulation (the Quick time and Howel time) and euglobulin lysis time (ELT). In order to search for the mechanism responsible for coagulability and fibrinolysis we studied the relations of these changes with the sympatheticoadrenergic system and with the adrenal hormonal secretion. Some parameters were thus explored after adrenalectomy and under the influence of a beta-blocking agent, Eraldin. Adrenalectomy moderately reduced these decreasing effects, excepting the ELT. Eraldin has a contrary effect. Adrenalectomy acts by suppressing the corticoid reaction and by diminishing the catecholamineones. Since Eraldin influences coagulation and fibrinolysis in an opposite sense than adrenalectomy, it may be concluded that catecholamines do moderate the effect of heating, inhibiting and not stimulating circulation, as assumed. On the contrary, corticoids (gluco- or mineralo-) contribute to the effect, influencing coagulation in hyperthermia. Both influences are slight, not determinant. Supplementary explorations revealed that repeated daily exposure for 1-2 or 3 weeks, simply in the cages in which hyperthermia was subsequently produced, decreased also the number of thrombocites, the QT and the ELT, especially the last one. The HT was less influenced. It results that these exposures, produced effects similar with hyperthermia. Heating rats after these daily repeated exposures does not influence these already changed parameters.

UI MeSH Term Description Entries
D008297 Male Males
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D011217 Practolol A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS. Dalzic,Eralzdin Practolol,ICI-50172,ICI 50172,ICI50172,Practolol, Eralzdin
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
January 1973, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
February 1971, Angewandte Chemie (International ed. in English),
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
January 1993, Zeitschrift fur Kardiologie,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
September 1973, Nihon rinsho. Japanese journal of clinical medicine,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
May 1974, Nihon rinsho. Japanese journal of clinical medicine,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
January 1964, Thrombosis et diathesis haemorrhagica,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
November 1995, Danish medical bulletin,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
October 1959, Medizinische Novitaten,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
January 1963, Annual review of medicine,
P Groza, and M Artino-Rădulescu, and E Nicolescu, and A Munteanu, and D Lungu
July 1999, Clinical science (London, England : 1979),
Copied contents to your clipboard!